OncLive SOSS

Authors

Ivan M. Borrello, MD

Latest:

Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple Myeloma

Ivan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.

Ivan M. Borrello, MD, Johns Hopkins Kimmel Cancer Center

Ivan Marques Borello, MD, Johns Hopkins

Ivan Marques Borello, MD, Johns Hopkinsk

Ivan Marques Borrello, MD, Johns Hopkins University

Ivy Altomare, MD, Duke

Ivy Altomare, MD, Duke&nbsp

Ivy Altomare, MD, Duke University Medical Center

Ivy Altomare, MD, Duke University School of Medicine

Ivy Altomare, MD, DukeÂ

Ivy P. Altomare, MD

Latest:

Dr. Altomare on Investigational Agents in ITP

Ivy P. Altomare, MD, discusses investigational agents in immune thrombocytopenia.

Izidore S. Lossos, MD

Latest:

Dr. Lossos on Research Questions in MCL

Izidore S. Lossos, MD, professor, director, Lymphoma Program Head of hematological malignancies site disease group, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses research questions in the field of mantle cell lymphoma (MCL).

J. Douglas Rizzo, MD, MS

Latest:

Dr. Rizzo on Impact of Age on Survival Outcomes in MDS After HCT

J. Douglas Rizzo, MD, MS, assistant scientific professor, Center for International Blood and Marrow Transplant Research, professor of Medicine, Medical College of Wisconsin, discusses a study that examined if age affects survival outcomes in patients with myelodysplastic syndromes who receive a hematopoietic cell transplant.

J. Kellogg Parsons, MD

Latest:

Dr. Parsons Discusses the Link Between Exercise and Bladder Cancer Risk

J. Kellogg Parsons, MD, associate professor of surgery (urology), University of California, San Diego, discusses modifiable lifestyle factors associated with bladder cancer.

J. Michael Dixon, MD

Latest:

Dr. Dixon on Prevalence and Risk Factors of Male Breast Cancer

J. Michael Dixon, MD, professor of Surgery, consultant surgeon, and clinical director of the Breakthrough Breast Cancer Research Unit at the University of Edinburgh in Scotland, discusses the prevalence of and risk factors for breast cancer in males.

J. Phillip Boudreaux, MD, FACS, Harvard Medical School

J. Russell Davis, MD

Latest:

Dr. Davis on Comparisons Between Robotic Surgery and Open Surgery in Lung Cancer

J. Russell Davis, MD, clinical professor, University of Missouri–Kansas City School of Medicine, thoracic surgeon, Saint Luke's Hospital, compares the use of robotic surgery with open surgery in patients with lung cancer.

J. Russell Hoverman, MD, PhD

Latest:

Ranking Value in Cancer Care: Analysis of a "Pathways" Approach

Amid a continuing debate over healthcare spending in the United States, the oncology community is growing more introspective about the costs associated with increasingly sophisticated cancer therapeutics.

Jack A. Roth, MD

Latest:

Dr. Roth Compares Surgery With SBRT in Lung Cancer

Jack A. Roth, MD, professor, Department of Thoracic and Cardiovascular Surgery, chief, Section of Thoracic Molecular Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, compares surgery with stereotactic body radiation therapy (SBRT) in patients with early-stage lung cancer.